5-methyl-11-(pyridin-3-ylamino)-10H-indolo[3,2-b]quinolin-5-ium chloride

ID: ALA1290717

Chembl Id: CHEMBL1290717

PubChem CID: 51051411

Max Phase: Preclinical

Molecular Formula: C21H17ClN4

Molecular Weight: 325.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[n+]1c2ccccc2c(Nc2cccnc2)c2[nH]c3ccccc3c21.[Cl-]

Standard InChI:  InChI=1S/C21H16N4.ClH/c1-25-18-11-5-3-9-16(18)19(23-14-7-6-12-22-13-14)20-21(25)15-8-2-4-10-17(15)24-20;/h2-13H,1H3,(H,23,24);1H

Standard InChI Key:  VSYJZDNZPNIIPS-UHFFFAOYSA-N

Associated Targets(non-human)

Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cathepsin B-like cysteine protease (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhodesain Rhodesain (1463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 325.40Molecular Weight (Monoisotopic): 325.1448AlogP: 4.44#Rotatable Bonds: 2
Polar Surface Area: 44.59Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.62CX Basic pKa: 5.41CX LogP: -0.80CX LogD: -0.81
Aromatic Rings: 5Heavy Atoms: 25QED Weighted: 0.47Np Likeness Score: -0.21

References

1. Lavrado J, Reszka AP, Moreira R, Neidle S, Paulo A..  (2010)  C-11 diamino cryptolepine derivatives NSC748392, NSC748393, and NSC748394: anticancer profile and G-quadruplex stabilization.,  20  (23): [PMID:20952194] [10.1016/j.bmcl.2010.09.110]
2. Lavrado J, Cabal GG, Prudêncio M, Mota MM, Gut J, Rosenthal PJ, Díaz C, Guedes RC, dos Santos DJ, Bichenkova E, Douglas KT, Moreira R, Paulo A..  (2011)  Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies.,  54  (3): [PMID:21207937] [10.1021/jm101383f]
3. Lavrado J, Mackey Z, Hansell E, McKerrow JH, Paulo A, Moreira R..  (2012)  Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives.,  22  (19): [PMID:22926067] [10.1016/j.bmcl.2012.07.104]

Source